Marksans Pharma Shows Strong Intraday Performance Amid Broader Market Gains

Marksans Pharma has shown significant activity today, with a notable gain of 5.03% as of March 24, 2025. The stock outperformed its sector by 4.51%, reaching an intraday high of Rs 229.95, reflecting a rise of 5.24%. In terms of moving averages, Marksans Pharma is currently above its 5-day and 20-day moving averages, although it remains below the 50-day, 100-day, and 200-day moving averages. In the broader market context, the Sensex has continued its upward trajectory, climbing 334.62 points to reach 77,790.89, marking a 1.15% increase. The Sensex has been on a three-week consecutive rise, gaining 6.27% during this period. Small-cap stocks are leading the market today, with the BSE Small Cap index up by 1.47%. Over various time frames, Marksans Pharma's performance has been mixed. While it has gained 58.49% over the past year, it has seen a decline of 22.16% year-to-date. However, its long-term performance remains strong, with a remarkable increase of 353.49% over the past three years and an impressive 2065.26% over the last five years.